Financhill
Back

Pro-Dex Quote, Financials, Valuation and Earnings

Pro-Dex Price Quote

$48.78
+0.11 (+5.24%)
(Updated: December 21, 2024 at 5:41 AM ET)

Pro-Dex Key Stats

Buy
59
Pro-Dex (PDEX) is a Buy

Day range:
$45.75 - $48.81
52-week range:
$16.18 - $54.84
Dividend yield:
0%
P/E ratio:
81.12
P/S ratio:
2.98
P/B ratio:
5.14%

Volume:
64.4K
Avg. volume:
37.3K
1-year change:
180.84%
Market cap:
$158.6M
Revenue:
$53.8M
EPS:
$1.53

How Much Does Pro-Dex Make?

Data Unavailable

Is Pro-Dex Growing As A Company?

Data Unavailable

Pro-Dex Stock Price Performance

  • Did Pro-Dex Stock Go Up Last Month?
    Pro-Dex share price went up by 2.18% last month
  • Did PDEX's Share Price Rise Over The Last Year?
    PDEX share price rose by 180.84% over the past 1 year

What Is Pro-Dex 52-Week High & Low?

  • What Is Pro-Dex’s 52-Week High Share Price?
    Pro-Dex has traded as high as $54.84 over the past 52 weeks
  • What Is Pro-Dex’s 52-Week Low Share Price?
    Pro-Dex has traded as low as $16.18 over the past 52 weeks

Pro-Dex Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Pro-Dex?

Data Unavailable

Is Pro-Dex Cash Flow Positive?

Data Unavailable

Pro-Dex Return On Invested Capital

Data Unavailable

Pro-Dex Earnings Date & Stock Price

  • What Is Pro-Dex's Stock Price Today?
    A single share of PDEX can be purchased today for 48.67
  • What Is Pro-Dex’s Stock Symbol?
    Pro-Dex trades on the nasdaq under the ticker symbol: PDEX
  • When Is Pro-Dex’s Next Earnings Date?
    The next quarterly earnings date for Pro-Dex is scheduled on February 7, 2025
  • When Is PDEX's next ex-dividend date?
    Pro-Dex's next ex-dividend date is May 27, 2020
  • How To Buy Pro-Dex Stock?
    You can buy Pro-Dex shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Pro-Dex Competitors

  • Who Are Pro-Dex's Competitors?
    Below is a list of companies who compete with Pro-Dex or are related in some way:
    • Perspective Therapeutics Inc (CATX)
    • InfuSystems Holdings Inc (INFU)
    • Retractable Technologies Inc (RVP)
    • Catheter Precision Inc (VTAK)
    • Xtant Medical Holdings Inc (XTNT)

Pro-Dex Dividend Yield

Data Unavailable

Pro-Dex Analyst Estimates

YoY Growth Past Surprise
EPS: 7.14% 158.62%
Revenue: 24.75% 23.07%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable